Global serum profiling: an opportunity for earlier cancer detection

Abstract The advances in cancer research achieved in the last 50 years have been remarkable and have provided a deeper knowledge of this disease in many of its conceptual and biochemical aspects. From viewing a tumor as a ‘simple’ aggregate of mutant cells and focusing on detecting key cell changes...

Full description

Bibliographic Details
Main Authors: Alexandra Sala, James M. Cameron, Paul M. Brennan, Emma J. Crosbie, Tom Curran, Ewan Gray, Pierre Martin-Hirsch, David S. Palmer, Ihtesham U. Rehman, Nicholas J. W. Rattray, Matthew J. Baker
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:https://doi.org/10.1186/s13046-023-02786-y
_version_ 1797555664401203200
author Alexandra Sala
James M. Cameron
Paul M. Brennan
Emma J. Crosbie
Tom Curran
Ewan Gray
Pierre Martin-Hirsch
David S. Palmer
Ihtesham U. Rehman
Nicholas J. W. Rattray
Matthew J. Baker
author_facet Alexandra Sala
James M. Cameron
Paul M. Brennan
Emma J. Crosbie
Tom Curran
Ewan Gray
Pierre Martin-Hirsch
David S. Palmer
Ihtesham U. Rehman
Nicholas J. W. Rattray
Matthew J. Baker
author_sort Alexandra Sala
collection DOAJ
description Abstract The advances in cancer research achieved in the last 50 years have been remarkable and have provided a deeper knowledge of this disease in many of its conceptual and biochemical aspects. From viewing a tumor as a ‘simple’ aggregate of mutant cells and focusing on detecting key cell changes leading to the tumorigenesis, the understanding of cancer has broadened to consider it as a complex organ interacting with its close and far surroundings through tumor and non-tumor cells, metabolic mechanisms, and immune processes. Metabolism and the immune system have been linked to tumorigenesis and malignancy progression along with cancer-specific genetic mutations. However, most technologies developed to overcome the barriers to earlier detection are focused solely on genetic information. The concept of cancer as a complex organ has led to research on other analytical techniques, with the quest of finding a more sensitive and cost-effective comprehensive approach. Furthermore, artificial intelligence has gained broader consensus in the oncology community as a powerful tool with the potential to revolutionize cancer diagnosis for physicians. We herein explore the relevance of the concept of cancer as a complex organ interacting with the bodily surroundings, and focus on promising emerging technologies seeking to diagnose cancer earlier, such as liquid biopsies. We highlight the importance of a comprehensive approach to encompass all the tumor and non-tumor derived information salient to earlier cancer detection.
first_indexed 2024-03-10T16:50:43Z
format Article
id doaj.art-580b7a572fd543ac8ff0b8e90d364bf2
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-03-10T16:50:43Z
publishDate 2023-08-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-580b7a572fd543ac8ff0b8e90d364bf22023-11-20T11:18:15ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662023-08-0142111510.1186/s13046-023-02786-yGlobal serum profiling: an opportunity for earlier cancer detectionAlexandra Sala0James M. Cameron1Paul M. Brennan2Emma J. Crosbie3Tom Curran4Ewan Gray5Pierre Martin-Hirsch6David S. Palmer7Ihtesham U. Rehman8Nicholas J. W. Rattray9Matthew J. Baker10Dxcover LimitedDxcover LimitedTranslational Neurosurgery, Department of Clinical Neurosciences, Royal Infirmary of EdinburghDivision of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of ManchesterChildren’s Mercy Research Institute, Children’s Mercy Kansas CityIndependent Health Economics ConsultantGynecological Oncology, Clinical Research Facility, Lancashire Teaching HospitalsDxcover LimitedSchool of Medicine, Faculty of Clinical and Biomedical Sciences, University of Central LancashireStrathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of StrathclydeDxcover LimitedAbstract The advances in cancer research achieved in the last 50 years have been remarkable and have provided a deeper knowledge of this disease in many of its conceptual and biochemical aspects. From viewing a tumor as a ‘simple’ aggregate of mutant cells and focusing on detecting key cell changes leading to the tumorigenesis, the understanding of cancer has broadened to consider it as a complex organ interacting with its close and far surroundings through tumor and non-tumor cells, metabolic mechanisms, and immune processes. Metabolism and the immune system have been linked to tumorigenesis and malignancy progression along with cancer-specific genetic mutations. However, most technologies developed to overcome the barriers to earlier detection are focused solely on genetic information. The concept of cancer as a complex organ has led to research on other analytical techniques, with the quest of finding a more sensitive and cost-effective comprehensive approach. Furthermore, artificial intelligence has gained broader consensus in the oncology community as a powerful tool with the potential to revolutionize cancer diagnosis for physicians. We herein explore the relevance of the concept of cancer as a complex organ interacting with the bodily surroundings, and focus on promising emerging technologies seeking to diagnose cancer earlier, such as liquid biopsies. We highlight the importance of a comprehensive approach to encompass all the tumor and non-tumor derived information salient to earlier cancer detection.https://doi.org/10.1186/s13046-023-02786-yLiquid biopsyBlood serumCancer detectionDiagnosisTumorigenesisMetabolism
spellingShingle Alexandra Sala
James M. Cameron
Paul M. Brennan
Emma J. Crosbie
Tom Curran
Ewan Gray
Pierre Martin-Hirsch
David S. Palmer
Ihtesham U. Rehman
Nicholas J. W. Rattray
Matthew J. Baker
Global serum profiling: an opportunity for earlier cancer detection
Journal of Experimental & Clinical Cancer Research
Liquid biopsy
Blood serum
Cancer detection
Diagnosis
Tumorigenesis
Metabolism
title Global serum profiling: an opportunity for earlier cancer detection
title_full Global serum profiling: an opportunity for earlier cancer detection
title_fullStr Global serum profiling: an opportunity for earlier cancer detection
title_full_unstemmed Global serum profiling: an opportunity for earlier cancer detection
title_short Global serum profiling: an opportunity for earlier cancer detection
title_sort global serum profiling an opportunity for earlier cancer detection
topic Liquid biopsy
Blood serum
Cancer detection
Diagnosis
Tumorigenesis
Metabolism
url https://doi.org/10.1186/s13046-023-02786-y
work_keys_str_mv AT alexandrasala globalserumprofilinganopportunityforearliercancerdetection
AT jamesmcameron globalserumprofilinganopportunityforearliercancerdetection
AT paulmbrennan globalserumprofilinganopportunityforearliercancerdetection
AT emmajcrosbie globalserumprofilinganopportunityforearliercancerdetection
AT tomcurran globalserumprofilinganopportunityforearliercancerdetection
AT ewangray globalserumprofilinganopportunityforearliercancerdetection
AT pierremartinhirsch globalserumprofilinganopportunityforearliercancerdetection
AT davidspalmer globalserumprofilinganopportunityforearliercancerdetection
AT ihteshamurehman globalserumprofilinganopportunityforearliercancerdetection
AT nicholasjwrattray globalserumprofilinganopportunityforearliercancerdetection
AT matthewjbaker globalserumprofilinganopportunityforearliercancerdetection